In conclusion, our results support our hypothesis that Aurora kinases are important KRAS targets in lung cancer and suggest Aurora kinase inhibition as a novel and specific approach to be explored for KRAS-induced lung cancer therapy. Here, KRAS is linked to lung cancer.